Post sponsored by

MIL OSI Translation. Region: Germany / Deutschland –

Source: CDU CSU

Madam President! Dear colleagues! Dear colleagues! We have all longed for a vaccine in the last few hard weeks, and if the one from BioNTech / Pfizer is expected to receive European approval before Christmas, then I will finally be a little more confident. It gives hope to all of us, and we can prevent so much suffering with this vaccine. It would simply be a wonderful Christmas present.

(Applause from the CDU / CSU and the SPD)

It would also not be an emergency approval, as in the USA or Great Britain; it would be the world’s first proper approval and, to be honest, I find it downright absurd to compete for the fastest approval in such a sensitive environment as vaccination.

(Applause from MP Daniela Ludwig [CDU / CSU])

First and foremost, we need people’s trust in vaccination and vaccines.

As is well known, Germany is also part of the European community. What is therefore not at all possible, for example, is to leave the smaller European partners – countries without their own capabilities and national vaccine approvals – behind and downright in the rain. And – I also say this – I am still proud – also as a European – that this mRNA vaccine, which for the first time also enables the industrial production of vaccines, was largely developed in Germany.

(Applause from the CDU / CSU and members of the SPD)

Dear colleagues, we will have 400,000 doses of vaccine available as early as December and 3 million from January. With the approval of the other vaccines and the further deliveries, we expect an increase in the first quarter of next year to 11 to 13 million doses. That is a lot, but it is not yet sufficient for comprehensive coverage, and it is therefore necessary to prioritize and determine who can be vaccinated first.

The STIKO, the Standing Vaccination Commission at the Robert Koch Institute, contributed its technical and scientific expertise, as did the Ethics Council and the Leopoldina, as with all vaccinations. In short, the aim is to use the vaccine as effectively as possible, so that death and serious disease are prevented as much as possible and the spread and risk of transmission are minimized.

If you put the whole thing in concrete terms, then that means first offering this vaccination to people over the age of 80, the people in the inpatient facilities who are treated, cared for and looked after there, or also those who work there. The group of people to be vaccinated would of course also include employees who are exposed to a high risk of infection in intensive care units, in emergency rooms or in the rescue service. In the medium term, the aim of the vaccination strategy is to offer everyone access to the vaccine – I emphasize: to offer it -; there is no compulsory vaccination.

(Applause from members of the CDU / CSU and the SPD)

Dear colleagues, the question of implementation remains. As legislators in the Third Civil Protection Act, we have laid the legal basis for precisely these deficiencies and commissioned the Minister of Health – and not, as usual, the Federal Joint Committee – in Section 20i SGB V, on the basis of this legal basis for Covid cases by means of a To determine ordinance.

We deliberately specified the criteria for the prioritization that may be necessary there. I quote from the reason:

In sentence 1 number 1 … with regard to vaccinations against the coronavirus … particularly relevant groups of people are named, namely if they have a significantly increased risk of a serious or fatal course of the disease when treating such people due to their age or previous health condition or maintain or if they have a key position in central areas of services of general interest and for the maintenance of central state functions.

One or the other may not have fully understood that. But I ask myself: what further sense should such a legal highlighting of persons have in this context?

We also need flexible measures in the next few months for ethical reasons, and they can only be flexibly adapted through statutory ordinances, namely if the vaccination proposals are repeatedly adapted in the next few weeks due to further or better evidence or because different types of vaccines are approved have to. That will be possible with legal regulations.

You will, dear colleagues from the FDP, Mr Thomae, introduce a bill tomorrow.

(Applause from the FDP)

In short, that means: referral to committee tomorrow, then a hearing and a vote.

(Stephan Thomae [FDP]: Because you haven’t done anything for so long! – Countercall from Deputy Alexander Dobrindt [CDU / CSU]: You are so late!)

Even if one assumes that there will be a majority: The next possible meeting of the Federal Council would be in February. That would mean: vaccine available in December, vaccination in February at the earliest – well!

Vice President Claudia Roth:

Mrs. colleague.

Karin Maag (CDU / CSU):

In any case, we start on December 18th.

Thank you very much.

(Applause from the CDU / CSU and the SPD – Alexander Dobrindt [CDU / CSU]: The FDP was sleeping! – Countercall from Deputy Christine Aschenberg-Dugnus [FDP]: You slept so long! – Another countercall from Deputy Stephan Thomae [FDP]: You haven’t woken up yet! – Another countercall from Deputy Dr. Wieland Schinnenburg [FDP]: You had time to do something all summer!)


EDITOR’S NOTE: This article is a translation. Apologies should the grammar and / or sentence structure not be perfect.

MIL Translation OSI